The assessment of out-of-office blood pressure (BP) using either ambulatory or home BP monitoring has allowed the detection of the masked hypertension (MH) and white-coat hypertension (WCH) phenomena. 1 Studies in adults have shown that WCH is associated with cardiovascular risk comparable with that of normotensives, whereas MH carries similar cardiovascular risk with uncontrolled hypertension. 1 In children and adolescents WCH and MH are not uncommon. [2] [3] [4] [5] [6] The 2004 Report of the National High Blood Pressure Education Program (NHBPEP) Working Group on High Blood Pressure in Children and Adolescents 7 discussed the issue of WCH but failed to mention MH.
Home BP monitoring has been extensively studied in the adults and is a regarded as a useful adjunct to office measurements. 1, 8 However, the evidence on home BP monitoring in children is limited; therefore, this method has not been even mentioned in the 2004 NHBPEP report. 7 Preliminary evidence suggests that in children and adolescents home BP monitoring is feasible, [9] [10] [11] [12] gives more reproducible values than office measurements, 13 and might be useful in hypertension diagnosis. 11, 14 Furthermore, recent studies have suggested the optimal schedule for home BP monitoring in children 15 and proposed thresholds for home BP normalcy for clinical use. 16 The objective of this study was to investigate the prevalence of WCH, MH, and sustained hypertension in children and adolescents assessed by home BP monitoring and to compare the characteristics of these subjects.
methodS
Participants. The Arsakeion study conducted at Psychico, a suburb of Athens, during the school year 2004-2005 was a prospective school-based study involving office and home BP measurements. The study was designed to investigate the normal range of home BP in children and adolescents, and these data have been published. 12, 16 In brief, healthy children and adolescents attending the Arsakeion School were invited to participate; we aimed to include 30 boys and 30 girls for each year of age in the age group of 6-18 years. Subjects suffering from acute or chronic illness or on drug treatment that might affect BP levels (nonsteroidal antiinflammatory dugs, corticosteroids, bronchodilators) in the last 15 days before study entry were excluded. The study protocol was approved 
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Studies using ambulatory blood pressure (BP) monitoring have shown that in children and adolescents masked hypertension (mH) is not uncommon. This school-based study investigated the prevalence and the characteristics of mH diagnosed using home BP measurements. methodS a total of 765 subjects aged 6-18 years were assessed with office (two visits, six readings) and home BP measurements (3 days, 12 readings). Office hypertension was diagnosed using the US Task Force normalcy tables and home hypertension using the arsakeion normalcy tables (≥95th percentile for both). White-coat hypertension (WCH) was defined as office hypertension but low home BP (<95th percentile) and mH as home hypertension but low office BP (<95th percentile).
reSultS
On the basis of office BP measurements of the first visit 3.3% of participants had mH, 5.9% WCH, and 2.7% hypertension compared to 4.2, 2.1, and 1.8%, respectively, when a two-visit-average BP was used (P < 0.001 vs. first visit). Subjects with mH or WCH did not differ from hypertensives or normotensives regarding age, gender, or height. However, weight, body mass index (BmI), waist and hip circumference, and office and home BP values fell in between those of normotensives and hypertensives. Prehypertension (office BP: 90-95th centile) and increased BmI were independent predictors of mH.
concluSionS
In children and adolescents mH detected by home BP monitoring is not uncommon and is associated with prehypertension and overweight. Repeated office measurements are essential for the precise diagnosis. mH and WCH in children appear to be intermediate phenotypes of hypertension. Measurements. Office BP measurements were taken in a quiet room in the school building by two trained physicians in two visits (routine school days) 1 week apart. An automated oscillometric device with memory and personal computer-link capacity was used (Omron 705 IT; Omron Healthcare Europe BV, Hoofddorp, the Netherlands), which has been validated for BP measurement accuracy in a subgroup of the study participants. 17 Three cuffs were available (inflatable bladder size 9 × 16, 13 × 23, and 15 × 30 cm) to fit the arm size of each individual (inflatable bladder length to be 80-100% of arm circumference). Measurements were taken on the left arm with the cuff at heart level. In left-handed subjects the right arm was used. Triplicate measurements were taken per visit after 5-min sitting rest and with 1 min between measurements (total of six readings per participant).
Home BP was taken by the participants or their parents (for younger children) on three consecutive routine school days between the two office visits using the same device, cuff and arm in each participant as for office BP measurement. Participants were asked to perform duplicate morning (after rising and before breakfast, 6:00 to 7:30 am) and evening measurements (before dinner, 5:00 to 7:00 pm), after 5-min sitting rest and with 1 min between readings (total of 12 readings per participant). The use of the device was explained to participants or to their parents. A handout with brief instructions was also provided. In children aged 6-12 years, the device and the instructions handout were given at school, and their parents were contacted by telephone to ensure that home measurements will be performed as required. Older children and adolescents, who preferred to self-monitor their home BP, were instructed in the use of the devices and performed a test self-measurement in the office. A form was given to participants to record their home readings. This was cross-checked against the printout obtained by the devices' memory through a personal computer. All home BP measurements (n = 12) were averaged to give a single number per individual (for systolic and diastolic BP).
In the first visit, height, weight, waist, hip, and arm circumference were measured, and information on medical history, use of drugs, and parental history of hypertension were obtained, which were verified and completed by telephone communication with their parents.
Hypertension classification. Office hypertension was defined as office BP ≥95th percentile for gender, age and height, prehypertension as 90-95th centile, and optimal BP as <90th centile based on the 2004 NHBPEP normalcy tables. 7 Home hypertension was defined as home BP ≥95th percentile for gender and height based on the Arsakeion study normalcy tables. 16 Normotension was defined as office and home BP being below the abovementioned thresholds and sustained hypertension as office and home hypertension. WCH was defined as office hypertension (but home BP being below the hypertension threshold) and MH as home hypertension (but office BP being below the hypertension threshold). 1, 5 Statistical analysis. Student's t-tests were used for the comparison of continuous variables in different subgroups of the study participants and paired t-tests for values obtained in the same subjects. Comparison of frequencies was performed by χ 2 -tests. One-way ANOVA was used to compare continuous variables among multiple subgroups and χ 2 for categorical variables. Bonferroni correction for multiple comparisons was applied where appropriate. All BP and adipocity indices were normally distributed and, therefore, only parametric tests were used. Logistic regression was used to determine potential predictors of MH among subjects with office BP <95th centile, with independent variables selected on the basis of previous reports in adults 18 and the results of subgroups by BP classification in this study. Body mass index (BMI) was expressed as z-score for height (strata of 10 cm), which has been previously shown to be the best index of obesity in this population. 19 Subsequently obesity was stratified according to BMI z-score (<0.0, 0.00-0.99, 1.00-1.99, ≥2.0). Receiver operator curve (ROC) analysis was performed in order to evaluate the sensitivity and specificity of BMI z-score (used as a continuous variable) to detect MH. A probability value of P < 0.05 was considered statistically significant. Analysis was performed using the Minitab statistical software (release 13.31; Minitab, State College, PA).
reSultS
A total of 778 children and adolescents were recruited and 765 (98%) of them who had office BP measurements in two visits and at least two valid home BP readings were analyzed. At least 8 of the 12 expected home BP readings were obtained by 93% of the participants. 16 Mean age was 12.3 ± 3.3 (s.d.) years (range 6.1-17.9), height 157.2 ± 17.8 cm (113-198), weight 50.2 ± 1.6 kg (16-135), waist 68.5 ± 10.4 cm (47-120), hip 80.9 ± 11.7 cm (55-123), arm circumference 23.0 ± 3.5 cm (14-37), and 358 (46%) were boys. Family history of hypertension (one or both parents) was reported in 152 participants (19.5%).
There was a small decline in office BP from the first to the second visit by 2 ± 8 mm Hg (95% confidence intervals 1.6, 2.7, P < 0.001) for systolic and 2 ± 7 mm Hg (95% confidence intervals 1.4, 2.4, P < 0.001) for diastolic ( Table 1) . Average home BP was 111 ± 10 mm Hg and diastolic 65 ± 6 mm Hg. The prevalence of sustained, WCH and MH on the basis of home BP and office BP of the first, the second, or the average of the two visits is presented in Figure 1 . When average office BP of two visits was used instead of the first visit only, there was a significant change in hypertension classification, with fewer participants classified as hypertensives and white-coat hypertensives and more as masked hypertensives (Figure 1 , P = 0.003). The same trend was observed when classification based on visit 1 was compared to that based articles Masked Hypertension in Children on visit 2, but did not reach statistical significance, neither did the comparison of classifications based on visit 2 vs. both visits 1-2 (Figure 1) . There was no difference between children (age 6-9 years, n = 211) and adolescents (age 10-18 years, n = 554) in the prevalence of sustained hypertension (2.4% vs. 1.6% for children and adolescents, respectively), WCH (2.8% vs. 1.8%), and MH (5.2% vs. 3.8%) (P = NS).
There was no difference between normotensives, white-coat, masked, and sustained hypertensives (diagnoses based on average office BP of both visits) regarding age, gender, height, and family history of hypertension. Mean weight, BMI, waist, hip, and arm circumference had their highest values in the hypertensive group and the lowest in the normotensive, with the white-coat and the masked hypertensives groups having intermediate values (P ≤ 0.001 for all, Table 2 ).
As expected office BP was higher in sustained and whitecoat hypertensives, whereas masked hypertensives had intermediate values compared to these two groups and the normotensives (ANOVA P < 0.0001, Table 2 ). On the other hand, home BP was higher in sustained and masked hypertensives, whereas white-coat hypertensives had intermediate values compared to these two groups and the normotensives (ANOVA P < 0.0001). Office pulse rate was higher in sustained and white-coat hypertensives whereas home pulse rate tended to be higher only in hypertensives ( Table 2) .
The prevalence of MH was higher (P = 0.001) among subjects with prehypertension (8/48, 16.7%) compared to those with optimal office BP (24/663, 3.5%). Furthermore, the prevalence of MH increased significantly (P = 0.001) from the lower to the higher level of BMI z-score (<0: 2.9% (12/407), 0-0.99: 3.7% (9/241), 1-1.99: 11.6% (8/69), ≥2: 16.7% (3/18)). Logistic regression analysis in subjects with office BP <95th centile (n = 735) showed that when age, gender, prehypertension, and BMI (z-score) were entered in the same mode (enter method) only prehypertension and BMI z-score were independent predictors of MH ( Table 3) .
The BMI z-score had statistically significant but yet moderate ability to predict the presence of MH (area under the curve: 0.65, P = 0.003, receiver operator curve). The specificity/sensitivity of BMI z-score cutoff 0, 1, and 2 were 62/64, 34/90, and 10/98, respectively. Using only BMI (z-score) to decide which subjects to investigate for MH, 90% of masked hypertensives are missed with z-score cutoff of 2 (3/32 are detected) and 66% are missed with cutoff ≤1 (11/32 are detected). The ability of prehypertension and obesity combined to detect MH used a z-score of 0 as threshold for BMI, and for office BP the 90th or 50th centile are shown in Figure 2 . BMI expressed as z-score for age yielded similar results (data not shown). Family his., parental history of hypertension. BP, blood pressure; BMI, body mass index; circ., circumference. * P = 0.05; **P < 0.01, ***P < 0.001 for difference among subgroups.
articles
Masked Hypertension in Children diScuSSion
This school-based study assessed the prevalence of MH and WCH among 765 healthy children and adolescents. To our knowledge this is the first study that investigated these phenomena using home BP monitoring in a large healthy population of children and adolescents. The main findings are that (i) MH and WCH can be detected by home BP monitoring, (ii) MH is twice as common as WCH or sustained hypertension, and (iii) prehypertension and obesity are the two independent predictors of MH. The finding of this study showing MH to be more common than WCH or sustained hypertension is in line with the results of a study conducted in Spain with 592 healthy subjects aged 6-18 years who attended an outpatient clinic for a preventive health check-up. 3 Interestingly, in that study, the diagnosis of MH was based on ambulatory BP monitoring as compared to home monitoring in the present study. These findings are important because three recent studies consistently showed that children and adolescents with MH have similar left ventricular mass as those with uncontrolled hypertension, whereas those with WCH do not differ from normotensives. 3, 4, 6 Unfortunately, in a large school-based study as the present one, it would be difficult to assess the extent of target organ damage.
Although the evidence on home BP monitoring in children is limited, preliminary data suggest that it might have a role in the management of pediatric hypertension. 11, 14 In this study an electronic device specifically validated in children, 17 which has automated memory to prevent the observer bias, ensured the reliability of measurements. Furthermore, the schedule used for home BP monitoring has been shown to provide reproducible values in children. 15 Finally, the only available diagnostic thresholds for home BP values obtained by distribution criteria in the same study 16 were used to define home hypertension. A recent study that compared the diagnostic value of home vs. ambulatory BP monitoring in children referred for elevated BP concluded that the two methods are interchangeable for the diagnosis of hypertension. 14 A potential limitation of this study is that for the classification of office hypertension, the 2004 NHBPEP normative tables were used (83,000 subjects aged 1-17 years), 7 whereas for home hypertension the only available normative tables were derived from the same study (Arsakeion). 16 Ideally all normative data should have been obtained in the same population, yet the Arsakeion study was too small to investigate office BP that is less reproducible than home measurements. 13 However, there is no evidence that different thresholds should be used to define hypertension in children in different countries, provided that age, gender, and body size are taken into account.
By averaging BP measurements of two office visits the prevalence of hypertension was reduced by about one-third and that of WCH by two-third (Figure 1) . These findings confirm the validity of the NHBPEP recommendation that BP assessment on several occasions is required to diagnose hypertension and that ambulatory monitoring is "especially helpful" in the evaluation of WCH. 7 On the other hand, as office BP is progressively reduced on repeated measurements, inevitably so, the prevalence of MH is increased. Similar to adults, the diagnosis of WCH and MH in children probably requires confirmation by repeated office and out-of-office BP measurements. 1 Despite having similar age, height, and gender distribution, white-coat and masked hypertensives in this study had intermediate indices of obesity (weight, BMI, waist, hip, and arm circumference) between those of normotensives and hypertensives ( Table 2 ). The strong association of high BP with obesity in children is well established. 7 Unfortunately the study power was too low to show differences between white-coat and masked or sustained hypertensives. However, these data suggest that both WCH and MH are intermediate phenotypes of hypertension and that obesity is a strong determinant of BP elevation. 7 Regarding pulse rate, the higher office values in white-coat and sustained hypertensives paralleled the office BP elevation and might reflect sympathetic system activation in the presence of the physician and the clinical setting. However, home pulse rate tended to increase only in the hypertensive group. The lack of a difference in family history of hypertension among the study subgroups might be due to the fact that BP was not measured in parents, which cannot exclude both under-and over-diagnosis of hypertension.
There is no question that children and adolescents with elevated office BP should be further investigated with out-ofoffice BP monitoring (home or ambulatory) to exclude WCH. 14 However, the diagnostic problem is MH, which will be missed if out-of-office BP is not assessed. Thus, the practical question is which children and adolescents to investigate for MH. 
Masked Hypertension in Children
This analysis suggested that prehypertension and obesity are the two independent predictors of MH. Subjects with prehypertension had about five times higher probability to have MH compared to those with optimal BP. However, 75% of masked hypertensives are missed if investigation is restricted to prehypertensives (Figure 2a) . If the office BP threshold for investigation is reduced to the 50th centile (which requires investigation of 68% of the study population), then the sensitivity to detect MH is increased to 87% even if BMI is ignored (Figure 2b) . On the other hand, if only the BMI z-score is used to decide whom to investigate for MH, in order to achieve an acceptable sensitivity (62%), the 0 threshold of BMI z-score should be applied (Figure 2) . By combining prehypertension and BMI z-score (level 0), again 1/3 of masked hypertensives are missed (Figure 2a) . Finally, MH can be safely excluded only in children with office BP <50th centile and BMI z-score <0. Overall these data suggest that there is no straightforward method to define an optimal approach to select subjects that require investigation for MH on the basis of office BP and BMI.
In conclusion, these data suggest that home BP monitoring might be useful in the detection of WCH and MH in children and adolescents. These phenomena are not uncommon and require careful assessment for a definite diagnosis to be made. Overweight children and adolescent with prehypertension in at least two office visits should be investigated for MH using out-of-office BP monitoring. Subjects with lower office BP and weight but close to the thresholds of prehypertension or overweight, respectively, should also be investigated. More research is needed to investigate the optimal approach for the evaluation and management of MH and WCH in children and adolescents. 
